Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
HONG KONG, Aug 11, 2025 – (ACN Newswire via SeaPRwire.com) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited interim results for the
More